Soufiane is co-Founder, co-President, and Chairman of the board of Nucleate Bio, Inc, a non-profit biotech organization that aims to empower the next generation of biotech leaders and facilitate the formation new life sciences companies solving the biggest problems in human and planetary health. Nucleate operates in 20 geographic regions across US and Europe and is currently expanding globally to create the world’s largest connected biotech community. He is also a PhD Candidate at Harvard Medical School in the lab of Professor George Church and his work at the Wyss Institute is focused on creating next-generation cellular therapies.

He previously served as the President of The Harvard Biotech Club, the worlds largest university biotech organization, has been a venture fellow at RA Capital Management, a scientific advisor to Nuveen, and has consulted for venture backed start-up companies. Passionate about open-access education, he has also consulted for Amgen LabXchange. Through his various roles as a biotech leader and consultant, Soufiane seeks to develop unique insights into life sciences innovation as it relates to entrepreneurship, company formation, development, and commercialization. His work bridges a vast network of biotech executives, investors, emerging top-talent, universities & hospitals, government and philanthropic leaders to advance life sciences innovation.